Brought to you by 
Series C brings $400mm to Relay Therapeutics
24 Jan 2019
Executive Summary
Relay Therapeutics Inc. (protein motion-based drug discovery; initial focus in oncology) raised $400mm through its Series C round from SoftBank Vision Fund (lead), new investors including Foresite Capital, Perceptive Advisors, and Tavistock Group, and returning backers GV, Casdin Capital, BVF Partners, EcoR1 Capital, Alexandria Venture Investments, and an affiliate of D.E. Shaw Research. This is the second-largest venture round in Strategic Transactions, behind Moderna Therapeutics' $450mm Series C in 2015.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Bioinformatics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Series C brings $400mm to Relay Therapeutics
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice